Showing results (21-30 of 135) with videos related to
Sort By:
Pageof 14
Clinics in Geriatric Medicine|November 1, 1989
Choice of antihypertensive medication regimenW B Applegate, S T MillerJAMA|March 22, 1985
Assessment of double-blindness at the conclusion of the beta-Blocker Heart Attack TrialR P Byington, J D Curb, M E MattsonAtherosclerosis|July 25, 1998
HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials dataJ R Crouse, R P Byington, C D FurbergThe American Journal of Medicine|April 17, 1989
Multicenter isradipine diuretic atherosclerosis study (MIDAS). Design features. The Midas Research GroupC D Furberg, R P Byington, N A BorhaniJournal of Cardiovascular Pharmacology|January 1, 1990
Multicenter study with isradipine and diuretics against atherosclerosis. US MIDAS Research GroupN O Borhani, S B Brugger, R P ByingtonThe American Journal of Cardiology|June 1, 1990
Propranolol-induced lipid changes and their prognostic significance after a myocardial infarction: the Beta-Blocker Heart Attack Trial experienceR P Byington, J Worthy, T Craven, et al.Journal of Clinical Epidemiology|January 1, 1990
Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study GroupR W Peters, R P Byington, A Barker, et al.Pharmacotherapy|January 1, 1989
Treatment of hypertension in the elderly with labetalolM A Sirgo, B K Boyd, W B ApplegateThe American Journal of Medicine|September 30, 1996
Tolerability, safety, and quality of life and hypertensive therapy: the case for low-dose diureticsM R Weir, J M Flack, W B ApplegateThe New England Journal of Medicine|April 26, 1990
Instruments for the functional assessment of older patientsW B Applegate, J P Blass, T F WilliamsPageof 14